TESERA: Advancing Morphologic Subtyping and Prognostic Stratification in Hepatocellular Carcinoma Using H&E Whole-Slide Images
Highlight
This article introduces TESERA, a novel computational pathology framework that extracts prognostically significant morphologic subtypes from hematoxylin and eosin (H&E) stained slides of hepatocellular carcinoma (HCC). TESERA identifies two distinct tumor subtypes linked to key molecular pathways and mutations, and provides a prognostic morphologic index predictive of overall and disease-free survival, validated across multiple cohorts.
TESERA’s approach utilizes routinely acquired histologic images, enabling low-cost and widespread biology-aware risk stratification, potentially guiding clinical management and therapeutic decisions in HCC.
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
